Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Search Interest in PDRN Has Surged. Here's What the Evidence Says About 'Salmon DNA' Skincare


News provided by

Laser by Aleya

Oct 13, 2026, 10:15 ET

Share this article

Share toX

Share this article

Share toX

GREAT NECK, N.Y., Oct. 13, 2026 /PRNewswire/ -- Google Trends data indicate that relative search interest for 'PDRN' in the U.S. increased 650% over the one-year period analyzed. Ahrefs data shows a similar pattern: the term itself is up 119%, "what is pdrn" is up 131%, and "pdrn cream" searches have climbed 371%.

Laser by Aleya, a laser hair removal and electrolysis studio in Great Neck, New York, explains what the ingredient does, especially since the science has moved faster than most headlines have caught up with.

What Is PDRN, and Why Is It Called "Salmon DNA"?
PDRN, or polydeoxyribonucleotide, refers to a preparation of purified DNA fragments traditionally derived from salmonid sources. That origin is also where the viral "salmon sperm facial" name comes from, which is a description built for attention rather than accuracy.

The clinical ingredient and the viral nickname describe the same material, but only one of those names explains what it actually does.

According to Google Trends, U.S. searches over the past year rose for product terms that use the clinical name and fell for "salmon pdrn":

Search term (U.S., past year)

Change

pdrn serum

+10 %

pdrn cream

+50 %

pdrn mask

+30 %

salmon pdrn

−30%

As interest in PDRN products has grown, interest in the "salmon" framing specifically has fallen. Consumers appear to be searching for the ingredient by its actual name more than the headline-grabbing one.

Ahrefs data shows search growth for "pdrn" itself, though the size of the increase depends on the year-over-year window measured:

Time frame (Ahrefs, "pdrn" searches)

Change

Oct 2024 to Oct 2025

+690 %

Dec 2024 to Dec 2025

+702 %

Jan 2025 to Jan 2026

+696 %

Feb 2025 to Feb 2026

+598 %

Mar 2025 to Mar 2026

+400 %

Oct 2025 to Oct 2026

+115 %

What Can a PDRN Serum Realistically Do, and What Can't It?
Until recently, the evidence behind topical PDRN was thin. That changed with a 2026 study in PLOS ONE, a randomized, double-blind trial of 31 women aged 35 to 55 who used a 0.1% PDRN eye cream on one side of the face and a matched retinol cream on the other for 28 days.

The PDRN side showed a 20% to 23% reduction in crow's-feet wrinkle area, compared with 6% to 7% for retinol, along with roughly double the improvement in skin elasticity, firmness, and dermal thickness.

No adverse reactions were reported in the study. That's one formulation, one concentration, and one small trial, not proof every PDRN product works the same way.

A 2026 systematic review identified seven eligible randomized trials involving 183 participants across skin rejuvenation, scar prevention, and wound-healing applications.

The review called the results promising, particularly for wound healing, but flagged small sample sizes and inconsistent protocols. A single eye cream study doesn't mean every PDRN serum on the shelf works the same way.

Serums vs. Injections: Why the Evidence Isn't Interchangeable
Separately, clinical evidence exists for injectable PDRN and polynucleotide treatments. In one split-face trial, 27 people received PN filler injections on one side and a hyaluronic acid filler on the other, around the eyes.

Overall aesthetic scores didn't differ significantly, although the PN side showed greater improvement in elasticity, hydration, and pore appearance on some measures, with no serious adverse events.

That evidence describes an injected product placed into tissue and not a cream applied to intact skin. No topical PDRN product sold as a cosmetic is the same thing as a clinical injectable.

Using PDRN Around Laser Hair Removal or Electrolysis
Skin just treated with laser hair removal or electrolysis is more sensitive than usual, so most practitioners recommend keeping aftercare simple, a gentle, hydrating product rather than introducing several new actives at once.

There is not yet enough evidence to say that a topical PDRN product provides a specific advantage after laser hair removal or electrolysis. Once the initial aftercare period has passed, any new product should be introduced cautiously.

"We tell clients to wait at least 24 to 48 hours after a session before adding anything new, PDRN included, and to patch test it on an untreated area first," said Aleya Bamdad, Founder & CEO of Laser by Aleya. "The skin barrier is already working overtime right after treatment, and a new active is one more variable if something goes wrong."

Choosing a PDRN Product Wisely
A product containing PDRN isn't automatically interchangeable with another one. Concentration, formulation, and what else is in the product all affect whether it does anything measurable.

Before trying a new PDRN product, especially on recently treated or sensitive skin, patch testing and checking the full ingredient list matter more than whether "PDRN" appears on the front of the label.

About Laser by Aleya
Laser by Aleya is an award-winning provider of professional New York laser and electrolysis hair removal services based in Great Neck. Founded by Aleya Bamdad, the clinic delivers personalized treatments supported by advanced laser technology and carefully selected beauty supplies. With over 20 years of experience, Laser by Aleya is committed to safety, education, and consistent results.

Media Contact
Aleya Bamdad
Founder & CEO
Laser by Aleya
[email protected]
(516) 551-8194

SOURCE Laser by Aleya

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Hormonal Facial Hair Is the Menopause Symptom No One Warns Women About

Menopause has a well-known symptom list: hot flashes, mood swings, sleepless nights. New or coarser facial hair rarely makes that list, even though...

At-Home Laser Devices Are Selling Fast. Here's What They Can and Cannot Do

The market for at-home IPL and laser hair removal devices is projected to grow from $1.76 billion to $1.93 billion this year alone, according to...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.